Impact of sarcopenia in advanced and metastatic soft tissue sarcoma.

Dennis StrassmannBennet HensenViktor GrünwaldKatharina StangeHendrik EggersFlorian LängerMohamed OmarPatrick ZardoHans ChristiansenChristoph W ReuterFrank K WackerArnold GanserPhilipp Ivanyi

Published in: International journal of clinical oncology (2021)

This study identifies sarcopenia as a prognostic parameter in a/mSTS. Further on, the data suggest that sarcopenia shows a trend of being associated with first line therapy response. SMI is a promising prognostic parameter, which needs further validation.

Keyphrases

skeletal muscle
community dwelling
squamous cell carcinoma
small cell lung cancer
genome wide
electronic health record
big data
gene expression
stem cells
dna methylation
deep learning
replacement therapy